Breast cancer drug gives hope of a cure, say emotional docs

AstraZeneca’s Enhertu slashed the risk of patients’ condition worsening or causing death by 72 percent compared with another drug. David Fredrickson, the firm’s head of oncology, reportedly said there were tears and cries of surprise when scientists saw the data. He added:

1 2 3